We rely on Catalent Pharma Solutions, LLC (Catalent), a contract development and manufacturing organization (CDMO) with proven GMP experience in the manufacturing of recombinant proteins for clinical…
DiaMedica Therapeutics Inc. Customers
No clients on recordNo downstream customers found in our database for DiaMedica Therapeutics Inc..
DiaMedica Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
DMAC-DEBT
Debt stack $212,000
90%
Market cache reports total debt of $212,000.
DMAC-DEBT-9090
Warrants outstanding: 607000
90%
xbrl warrant detail from xbrl 2018-12-31.
DiaMedica Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for DiaMedica Therapeutics Inc..
DiaMedica Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
DMAC-OWNER-COOPERMAN-LEON-G
COOPERMAN LEON G
90%
13F overlay lists COOPERMAN LEON G as top holder; 98 tracked holders.
DiaMedica Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.